Our platform yields valuable insights from clinical information and genetic data, empowering us to enhance patient outcomes. At Abiomix, we build next generation AI-based tools and offer services to simplify clinical and genetic data. Our platform is your integrated solution, from sample to research-based analysis, to clinical insights.
our goal is to simplify the way genetic data is analysed and make it simple, fast and accurate. we aim to deliver innovative and creative solutions to meet the needs of our customers across the globe.
In the constantly growing field of genetics, Abiomix stands out as a leader in innovation and making things simple. With more than ten years of experience, we've been at the forefront of change, working to meet the industry's demand for more efficient ways to analyze data.
We develop tools and services that change the way data is examined and used. Our collaborative spirit knows no bounds, as we strive to bridge the gap between genetic data and groundbreaking clinical insights. Abiomix extends its presence to the Middle East, Asia, and Africa.
A platform that combines SNV, Indels, CNV analysis
Analysis of germline cancer variants
Trio and Carrier screening reporting
An easy-to-use platform designed for handling large sample sizes
Tailored integration of clinical data and genetic information
In a game-changing move, Litpeaks has acquired Abiomix, merging cutting-edge technology with biotech expertise, poised to revolutionize healthcare.
See more
In a game-changing move, Litpeaks has acquired Abiomix, merging cutting-edge technology with biotech expertise, poised to revolutionize healthcare.
See more
In a game-changing move, Litpeaks has acquired Abiomix, merging cutting-edge technology with biotech expertise, poised to revolutionize healthcare.
See more1 hours
Web Conferencing details provided upon confirmation
UTC+4 (Time zone of Abu Dhabi, United Arab Emirates)
Schedule Now